Literature DB >> 32229200

Maternal alcoholism and neonatal hypoxia-ischemia: Neuroprotection by stilbenoid polyphenols.

Ursule Dumont1, Stéphane Sanchez2, Benjamin Olivier3, Jean-François Chateil4, Denis Deffieux5, Stéphane Quideau6, Luc Pellerin7, Marie-Christine Beauvieux8, Anne-Karine Bouzier-Sore9, Hélène Roumes10.   

Abstract

The impact of maternal nutrition on neurodevelopment and neonatal neuroprotection is a research topic with increasing interest. Maternal diet can also have deleterious effects on fetal brain development. Fetal exposure to alcohol is responsible for poor neonatal global development, and may increase brain vulnerability to hypoxic-ischemic encephalopathy, one of the major causes of acute mortality and chronic neurological disability in newborns. Despite frequent prevention campaigns, about 10% of women in the general population drinks alcohol during pregnancy and breastfeeding. This study was inspired by this alarming fact. Its aim was to evaluate the beneficial effects of maternal supplementation with two polyphenols during pregnancy and breastfeeding, on hypoxic-ischemic neonate rat brain damages, sensorimotor and cognitive impairments, in a context of moderate maternal alcoholism. Both stilbenoid polyphenols, trans-resveratrol (RSV - 0.15 mg/kg/day), and its hydroxylated analog, trans-piceatannol (PIC - 0.15 mg/kg/day), were administered in the drinking water, containing or not alcohol (0.5 g/kg/day). In a 7-day post-natal rat model of hypoxia-ischemia (HI), our data showed that moderate maternal alcoholism does not increase brain lesion volumes measured by MRI but leads to higher motor impairments. RSV supplementation could not reverse the deleterious effects of HI coupled with maternal alcoholism. However, PIC supplementation led to a recovery of all sensorimotor and cognitive functions. This neuroprotection was obtained with a dose of PIC corresponding to the consumption of a single passion fruit per day for a pregnant woman.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Maternal alcoholism; Maternal supplementation; Neonatal hypoxia-ischemia; Neuroprotection; Polyphenols

Mesh:

Substances:

Year:  2020        PMID: 32229200     DOI: 10.1016/j.brainres.2020.146798

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Hannah Youngblood; Yong Li; Xuemei Zong; Lei Li; Tongda Xu; Quanguang Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

2.  Neuroprotective Effect of Eco-Sustainably Extracted Grape Polyphenols in Neonatal Hypoxia-Ischemia.

Authors:  Hélène Roumes; Stéphane Sanchez; Imad Benkhaled; Valentin Fernandez; Pierre Goudeneche; Flavie Perrin; Luc Pellerin; Jérôme Guillard; Anne-Karine Bouzier-Sore
Journal:  Nutrients       Date:  2022-02-12       Impact factor: 5.717

3.  Selective Extraction of Piceatannol from Passiflora edulis by-Products: Application of HSPs Strategy and Inhibition of Neurodegenerative Enzymes.

Authors:  Luana Cristina Dos Santos; Jose Antonio Mendiola; Andrea Del Pilar Sánchez-Camargo; Gerardo Álvarez-Rivera; Juliane Viganó; Alejandro Cifuentes; Elena Ibáñez; Julian Martínez
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 4.  Nutraceuticals in the Prevention of Neonatal Hypoxia-Ischemia: A Comprehensive Review of their Neuroprotective Properties, Mechanisms of Action and Future Directions.

Authors:  Marta Reyes-Corral; Noelia Sola-Idígora; Rocío de la Puerta; Joan Montaner; Patricia Ybot-González
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

5.  Supplementation with dietary omega-3 PUFA mitigates fetal brain inflammation and mitochondrial damage caused by high doses of sodium nitrite in maternal rats.

Authors:  Jingchi Sun; Weishe Zhang
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.